3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Prostatic Neoplasms
15
Carcinoma, Non-Small-Cell Lung
9
Uterine Cervical Neoplasms
7
Colonic Neoplasms
6
Breast Neoplasms
5
Uterine Cervical Dysplasia
4
Urinary Bladder Neoplasms
4
Papillomavirus Infections
3
Neuroblastoma
3
Melanoma
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Esophageal Neoplasms
3
Brain Neoplasms
3
Anus Neoplasms
3
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Squamous Intraepithelial Lesions
2
Rectal Neoplasms
2
Precancerous Conditions
2
Oropharyngeal Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Liver Neoplasms
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
HIV Infections
2
Interventions
relatlimab
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Pregnancy Tests
1
Ocoxin
1
Nivolumab
1
Human Papillomavirus DNA Tests
1
Colposcopy
1
Biopsy
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Female Urogenital Diseases and Pregnancy Complications
×
Watchful Waiting
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled